𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting NF-κB in hematologic malignancies

✍ Scribed by Braun, T; Carvalho, G; Fabre, C; Grosjean, J; Fenaux, P; Kroemer, G

Book ID
110017175
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
249 KB
Volume
13
Category
Article
ISSN
1350-9047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AKT/NF-κB inhibitor xanthohumol targets
AKT/NF-κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies
✍ Raffaella Dell'Eva; Claudia Ambrosini; Nicola Vannini; Giovanna Piaggio; Adriana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

## Abstract ## BACKGROUND. Leukemias are dependent on Akt/NF‐κB activation and angiogenesis. ## METHODS. The antiangiogenic Akt/NF‐κB inhibitor xanthohumol (XN) has in vitro activity against acute and chronic myelogenous leukemia cell lines (AML, CML) and fresh samples from patients were investi

NF-κB and cancer: Mechanisms and targets
NF-κB and cancer: Mechanisms and targets
✍ Michael Karin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

## Abstract In addition to being a central coordinator of immune responses, NF‐κB signaling also plays a critical role in cancer development and progression and it may determine the response to therapy. NF‐κB activation was shown to provide a critical mechanistic link between inflammation and cance